Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000176
Status:
COMPLETED
Last Update Posted:
2010-11-05
First Post:
1999-10-29
Brief Title:
Alzheimers Disease Prevention Trial
Sponsor:
National Institute on Aging NIA
Organization:
National Institute on Aging NIA
Study Overview
Official Title:
Alzheimers Disease Prevention Trial A Multi-center Randomized Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimers Disease and Loss of Memory in Women
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a three-year study to determine if estrogens can prevent memory loss and Alzheimers disease in women with a family history of Alzheimers disease
Detailed Description:
PREventing Postmenopausal memory loss and Alzheimers with Replacement Estrogens PREPARE is a double-blind-placebo controlled trial to determine whether estrogen or estrogen and progesterone can delay the onset of memory loss or Alzheimers Disease in elderly women with a family history of the disease
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RO 1AG15922-01 | None | None | None |